TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15435 · Jan 25

#shell#archlinux#baby_sched#cachy#cachy_scheduler#cachyos#cacule_sched#kernel#linux_kernel#performance#performance_tuning CachyOS offers enhanced Linux kernels with schedulers like BORE for gaming, EEVDF for general use, and BMQ, plus variants for security, servers, real-time, and Steam Deck. They include advanced optimizations like LTO, profile-guided compilation, AMD P-State boosts, ZFS/NVIDIA support, and CPU-specific builds (x86-64-v3/v4, Zen4). Easy repo install auto-detects your CPU for top performance. This boosts your system's speed, responsiveness, and efficiency on modern hardware, making gaming, daily tasks, and heavy workloads smoother and faster. https://github.com/CachyOS/linux-cachyos

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment